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iabetes, a syndrome characterized by high plasma glucose and low plasma insulin concentrations, is associated with somatic and autonomic neuropathies as well as cardiac and vascular disorders.
These consequences of diabetes significantly affect the organism's ability to maintain homeostasis. To understand the changes associated with diabetes, we developed a laboratory exercise that compares and contrasts the cardiovascular responses to exercise in an individual with diabetes and in an individual without diabetes. This exercise provides a unique opportunity to analyze, integrate, and interpret the changes associated with diabetes, since more is learned about how a system operates when the system is forced to perform than when it is idle. In this laboratory, anatomical and physiological data concerning diabetes are provided. Subsequently, a figure that illustrates the response of a specific cardiovascular variable during exercise (e.g., heart rate, cardiac output, blood pressure) is presented.
Students are challenged to analyze and assimilate information from figures, answer questions, make calculations, fill in tables, and plot graphs. The laboratory does not require equipment or software, only rulers and pencils. The answers to the questions and tables are provided in the APPENDIX. Students obtain experience in evaluating and understanding diabetes as well as applying basic cardiovascular concepts. The emphasis is on the application of basic cardiovascular principles, interpretation of pictorial or tabular material, and problemsolving skills.
Teachers are constantly searching for new and innovative methods of engaging students in interactive learning. One innovative method of teaching basic physiological concepts is to compare and contrast systems in physiological (nondisease states) and pathophysiological (special populations) conditions. This method is similar to that used by researchers when investigating physiological systems. Investigators perturb the system to understand its response and therefore its function. In this context, teachers can use special populations to teach function because disease states also perturb the system, which results in specific responses. This method utilizes a practical living process to dissect basic concepts while at the same time understanding a specific disease state.
Dynamic exercise can also be used as an educational tool, since more can be learned about how a system operates when the system is forced to perform than
when it is idle (1, 2) . For example, significantly more can be learned about how the cardiovascular system functions during exercise than at rest. In this manuscript, we present a laboratory experience that utilizes a disease state (diabetes) and exercise to teach basic physiological concepts.
Individuals with diabetes mellitus, a syndrome characterized by high plasma glucose and low plasma insulin concentrations, are subject to anatomical and physiological changes that significantly affect the response to internal and external stimuli (homeostasis). Homeostasis is maintained, in part, by adjustments in the cardiovascular, endocrine, and nervous systems. However, individuals with diabetes have a reduced ability to compensate for changes in homeostasis due to significant changes in these systems. These reduced abilities to respond to changes in homeostasis are dramatically illustrated during the stress of exercise. In this context, we developed a laboratory exercise to assist students in understanding the cardiovascular adjustments made during a time when the regulatory components of the cardiovascular system are fully active, that is, during exercise, in individuals with and without diabetes.
The purpose of this laboratory exercise is to present an interactive teaching tool that helps students understand the anatomical and physiological limitations that exist in an individual with diabetes. In addition, students will learn basic cardiovascular principles. To this end, we developed a laboratory exercise that presents a series of pretest questions concerning anatomical and physiological differences between individuals with and without diabetes. Subsequently, a narrative is presented describing basic anatomical and physiological characteristics of an individual with diabetes. The unique consequences of diabetes give rise to cardiovascular responses that are specific to the limitations that exist in the individual with diabetes. Students are challenged to compare and contrast the cardiovascular components during exercise between individuals with and without diabetes. Through the use of reading and plotting graphs, the students answer questions, fill in tables, and make calculations related to the figure. The answers to all questions and tables are provided.
PEER EVALUA'I'ION
This laboratory exercise, along with two similar exercises examining the cardiopulmonary changes associated with aging and congestive heart failure, was presented at an Educational Materials Workshop at the annual meeting of the American College of Sports Medicine in Indianapolis, IN, in 1994. The Educational Materials Workshop presented a specific laboratory exercise each day for three consecutive days. The first-day workshop was entitled "The Cardiopulmonary Changes Associated with Aging," the second-day workshop was entitled "The Cardiopulmonary Changes Associated with Congestive Heart Failure," and the third-day workshop was entitled "The Cardiopulmonary Changes Associated with Diabetes. " Each workshop was conducted in a 3-h period. D uring the 3-h period, participants were introduced to the educational tool in a poster format. The poster consisted of a condensed version of the educational material. In addition, a slide presentation was available. During the slide presentation, participants could advance the slides at their own pace and experience how the tool could be used in the classroom. Finally, hard copies were available, along with paper and pencils, so that participants could sit down and experience how the tool could be used in a laboratory/interactive setting. The workshop was designed to be informal and interactive. There were no time restraints, and participants could avail themselves of any of the three presentation formats and come and go at their convenience. During the workshop, the poster, slides, and hard copies were offered simultaneously. The authors were readily accessible during each workshop to answer questions, share ideas on education, and encourage interaction.
Individuals who participated in the laboratory exercise included physicians, nurses, physical therapists, cardiac and pulmonary rehabilators, educators, and scientists. Based on comments and interactions at the conference, as well as the communication with participants upon returning home (including requests for the materials), we believe that this format of presenting the information and materials was extremely well received. The following are excerpts from letters received after the meeting: "Your con-cept is truly the direction that educators in our Jzeld should be striving to accompZish...Your material would be extremely useful for my Exercise Science students during their clinical rotations," Joe Sagorsky, MS, Manager, Health Promotion Services; "Your education packets will provide exceptional learning experiences for our graduate students," Shala Davis, PhD, College of Education, Virginia Polytechnic Institute and State University; "As I complete nearly 35 years of teaching in higher education, I'm still attracted to new and innovative ideas such as yours, " M. Thomas Woodall, PhD, Director ofAdult Fitness/Cardiac Rehabilation, Director of Human Performance Laboratory, Eastern Illinois University; "I will be oRering a workshop on Exercise Physiology in Clinical Populations in the fall (f993J. 2% is workshop is for exercise pbysiologists, nurses, and other rebab health professionals. I would like to incorporate some active learning activities in this workshop and was excited to see the work you bad done in this area," Karen Toft Dorn, Department of Nursing, Augustana College; "I was vev impressed with this educational experience and think it would be very useful in the course I teach in cardiopulmonary physical therapy," Tanya K. LaPier 
important component for innovative interactive learning.
SLJMMARY
The purpose of this educational material was to provide an innovative and interactive teaching tool that helps students and researchers understand the cardiovascular changes during exercise in individuals with and without diabetes. The educational tool can be used in a classroom and/or in a laboratory setting for undergraduate, graduate, and nursing students as well as for professionals in cardiac and pulmonary rehabilitation. From the presentation experience and the comments received, the educational material proved to be a valuable teaching tool.
APPENDIX: THE LABORATORY EXERCISE

Subjects
The subjects presented in this laboratory exercise are hypothetical SO-yr-old individuals. One individual has diabetes, and the other individual does not. Basic anatomical and physiological data for these individuals are provided in BACKGROUND INFOR-
MATION.
Time Required
Approximately 4.0-5.0 h are required for completion. If adequate laboratory time is not available, it may be necessary to complete this exercise during out-of-class time.
Level of Difficulty
Students attempting this laboratory exercise should have completed the cardiovascular section of an undergraduate physiology course. It would be suitable for undergraduate, graduate, premedical, medical, nursing, and allied health students. It requires that students be able to read data in graphical and tabular form, perform simple mathematical calculations, fill in tables, and plot data on graphs.
Equipment Required
A pen/pencil, ruler, paper, and calculator are needed.
A basic understanding of cardiovascular regulation at rest and during exercise is required.
Notes to the Instructor
This laboratory exercise is very straight forward but does require a degree of independence and initiative on the part of the student. Depending on the nature of your student population, you may find it preferable to place your students in small groups. This may facilitate a general discussion of each mechanism and help any students who may experience difficulty with a specific section. The group dynamics may facilitate a more thorough understanding of each mechanism through the group discussions and attempts at answering the questions.
It is at your discretion whether or not this exercise is conducted in specified laboratory time or whether students should be allowed to conduct the exercise outside of the normal laboratory time. Some possible options you might want to consider are 1) conduct an in-class discussion of the basic anatomical and physiological concepts associated with diabetes, 2) help students work through the initial sections of the laboratory exercise, and encourage students to finish the exercise in small groups or individually, or 3) instruct the students on whether you prefer that they work in groups or individually and then have them complete the exercise on their own. If the students are instructed to work during their own time, you may wish to use your laboratory time to discuss their answers and any areas that prove problematic to them. The manner in which you conduct this exercise depends very much on the student's background and level of understanding of physiology.
Objectives
The specific objective of this laboratory is to reinforce an understanding of the relationships between various cardiovascular variables and how they are altered in individuals with diabetes. This specific objective will be met once the following goals have been achieved. Goal 1. The first goal is to acquire a better understanding and ability to integrate and apply various principles of cardiovascular physiology.
GoaZ2. The second goal is to apply these principles of cardiovascular physiology at rest and during exercise in an individual with and without diabetes.
Goal 3.
The third goal is to analyze and assimilate information from figures, answer questions, make calculations, fill in tables, and plot graphs.
PRETEST QUESTIONS
Pretest questions are designed to prepare students for the laboratory exercise. The questions should focus the student's thinking and should prepare the student for the concepts that are developed in the exercise. The questions are not designed to determine or establish a knowledge base, rather the questions should prepare the student for the "brain strain" of the exercise.
1. List the anatomical (myocardial and vascular changes) and physiological [maximum oxygen consumption (Go2 max), resting heart rate (HR), and cardiac output (CO)] differences between individuals with and without diabetes.
2. An individual without diabetes can increase HR and, to a small extent, stroke volume (SV) due to circulating catecholamines released by sympathetic efferent nerve endings and the adrenal medulla. Can the individual with diabetes, working at the same percentage of ?ozmax as the individual without diabetes, take advantage of this mechanism?
3. Consider the components of the autonomic nervous system that mediate the HR and contractility response to exercise. How might this response be altered in an individual with diabetes who has a decline in both parasympathetic withdrawal and P1-adrenoreceptor responsiveness?
4. Predict which individual would have the higher resting HR? Which individual would have the lower maximum HR? Which individual would 5.
6 .
7.
8.
9
. compromised nervous function, metabolic changes (increased plasma glucose and free fatty acid concentrations, disturbances in plasma and cellular lipid and carbohydrate metabolism), and conversion of hemoglobin to hemoglobin AI,. Hemoglobin Al, binds to oxygen more tightly compared with the normal hemoglobin and is a direct result of glucose binding to the hemoglobin molecule.
2. Unfortunately, the individual with diabetes is not able to take full advantage of catecholamines released by the sympathetic nerve endings and the adrenal medulla. Diabetes is often associated with autonomic neuropathies that delay and impair the release of norepinephrine from the sympathetic efferent nerve terminal and from the adrenal gland. In addition, a decreased number of cardiac PIadrenoreceptors, which reduces contractility, also contributes to a diminished SV response to increasing workloads.
3. At the onset of exercise, there is a centrally generated signal that simultaneously activates cardiovascular, respiratory, and motor centers (central command Despite an initial increase in SV, several factors limit its potential. An increase in afterload due to stiffening of the arterial vasculature that opposes the increase in SV, a diminished response to P,-adrenoreceptor responsiveness that attenuates the increase in contractility, and a decreased ventricular compliance that limits the increase in EDV will all result in an attenuated SV response during exercise.
6. In the individual without diabetes, resting CO is -5.6 l/min [SV (70 ml) x HR (80 beats/min)].
Although an individual with diabetes has a similar CO at rest (4.93 l/min), the diabetic myopathies and neuropathies elevate resting HR (90 beats/min) and
reduce resting SV (55 ml). Thus CO is limited at rest due to a reduction in SV. During exercise, CO is limited in the individual with diabetes due to the attenuated HR and SV responses during exercise.
7. Diabetes is associated with an increased incidence of atherosclerotic and hypertensive diseases and cardiomyopathies. Unfortunately, these cardiac diseases are not clinically diagnosed until the pathological processes are far advanced. In spite of these changes in the heart and vasculature, resting MAP is similar between individuals with and without diabetes. The increase in MAP for individuals with and without diabetes is also similar through increasing workloads. However, the factors that contribute to the gradual increase in MAP are very different. In the individual without diabetes, MAP rises as a result of gradually increasing CO and decreasing total peripheral resistance. Systolic blood pressure (SBP) continues to rise as diastolic blood pressure (DBP) slowly decreases with increasing workloads. In contrast, the individual with diabetes increases MAP partially from an increase in CO but primarily from an attenuation of the decrease in total peripheral resistance. Initially, SBP accounts for the rise in MAP, and, once SBP levels off, DBP increases and maintains the gradual rise in MAP.
8. In both individuals, Voz,, is limited by a maximal CO. That is, the metabolic demands set by the active muscle during exercise cannot be met by the pumping capabilities of the heart. In the individual with diabetes, numerous hematological changes are evident. For example, erythrocytes deform less rapidly, which impedes their passage through arterioles into capillaries. Erythrocytes also spend a greater proportion of time in the arterial end of the capillary compared with the venous end, and hemoglobin Al, is increased. Hemoglobin Al, is a direct result of the hyperglycemia that increases the affinity of oxygen to the hemoglobin molecule. This results in a situation in which oxygen is not easily removed from the hemoglobin molecule. In addition to these hematological alterations, capillary basement thickening occurs, which increases the distance for the diffusion of oxygen. However, despite these changes, a-v oxygen difference between the two individuals differs very little at rest and with increasing workloads. Individuals with diabetes who demonstrate a greater incidence of cardiomyopathies also have higher triglyceride levels. Acute exercise in individuals with diabetes reduces the level of triglyceride by using more fat for energy than glucose at moderate levels of exercise. The lower triglyceride concentration will in turn reduce the production of atherosclerotic plaques within the coronary arteries. However, a strenuous exercise program that results in excessive cardiovascular stress may be detrimental in an individual with diabetes. For example, the distribution in blood flow is altered in the individual with diabetes because of the reduction in CO and impaired local vascular regulatory mechanisms. At any given workload, the viscera will receive less than their usual blood flow to facilitate the increase in blood flow to the active skeletal muscle. The individual with diabetes associated with advanced nephropathy may develop ischemia to the organs and possibly renal insufficiency. Individuals with diabetes demonstrate an augmented rise in DBP in response to exercise. The increased pressure may result in undue stress to the microvasculature of the eye and kidney and provoke hemorrhage. Finally, perceptions and pain thresholds in the lower extremities are often elevated in individuals with diabetes. Somatic neuropathy may result in severe foot damage due to the recurrent compression of the foot during prolonged walking or running. The damage will occur without recognition.
10. There are several advantages to an exercise training program. Exercise training in the individual with diabetes improves insulin sensitivity. In turn, insulin enhances glucose uptake and glucose metabolism by increasing the activity of glycogen synthetase (an enzyme responsible for the conversion of glucose to its storage form of glycogen). In addition, exercise training increases activity of lipoprotein lipase in the muscle and increases the ability of the muscle to take up and oxidize free fatty acids. Thus the plasma concentration of triglycerides is decreased. Cardiovascular fitness in individuals with diabetes is improved after an exercise training program. For example, Vozmax is significantly elevated.
Resting SBP and HR are decreased after training. In addition, a lower HR at a constant workload is achieved. The lower HR at a constant workload is beneficial such that the HR reserve or the ability to further increase HR is increased. As a result of the cardiovascular adjustments to exercise training, exercise tolerance is enhanced. The enhancement is demonstrated by an increase in the maximal workload achieved and an increase in the time to reach fatigue.
BACKGROUND INFORMATION
Individuals with chronic exposure to elevated plasma glucose concentrations often develop peripheral neuropathies (affecting the autonomic and somatic nervous systems), cardiac myopathies, and alterations in vascular and myocardial compliances. Neuropathy occurs as a result of structural and biochemical changes within the nerves. Functionally, this results in abnormal neural regulation due to degeneration of neuronal tissue and decreases in neuronal enzyme activity that impair and delay the response of the autonomic nervous system. Cardiac myopathies are characterized by a decrease in cardiac contractility, rate of myocardial relaxation, SV, ejection fraction, and a higher left ventricular enddiastolic pressure. This is due to a decreased number of cardiac p,-adrenoreceptors, impaired myocardial calcium metabolism, and a decrease in myocardial compliance.
The elastic components (compliance) of the arteries and heart are decreased in the individual with diabetes. Vascular compliance is a measure of the expansion and recoil properties of the vessel during
each cardiac cycle and provides the energy for a constant MAP and blood flow. An individual with diabetes has a decreased aortic compliance due to collagen infiltration into the vessel wall, interstitial accumulation of connective tissue, and a perivascular thickening of the basement membrane. Consequently, the aorta becomes less expandable. Under normoglycemic conditions, the aorta expands. during the rapid ejection phase of the cardiac cycle. Expansion of the aorta simultaneously absorbs the energy imparted by the ejected blood. If the aorta fails to adequately expand (decreased compliance), the energy is not absorbed, and SBP increases. Functionally, this results in an increased SBP. However, individuals with diabetes also demonstrate a decrease in SV. Therefore, SBP is usually lower in individuals with diabetes. DBP is also affected by the decreased aortic compliance. DBP decreases due to the loss of the windkessel effect when the aorta fails to recoil adequately. However, diabetes is also associated with an increase in total peripheral resistance, which functions to increase DBP. Thus these individuals usually demonstrate an increase in DBP. An individual with diabetes also has a decreased myocardial compliance due to collagen infiltration into the myocardial tissue. Similarly, the heart is less distensible and does not expand well during diastole. The physiological consequence is a reduction in SV. Because SV is a component that determines CO, CO is, in turn, reduced.
Individuals with chronic exposure to elevated plasma glucose concentrations often develop increases in blood volume. The high plasma glucose concentration elevates plasma osomolality, which stimulates hypothalamic osmoreceptors to release arginine vasopressin. Arginine vasopressin functions to increase water reabsorption in the kidney. The increase in blood volume is an effort to decrease plasma osomolality. However simultaneously, the increase in blood volume is opposed by glucosemediated osmotic diuresis and the inhibitory effects on renin and aldosterone.
Taken together, the individual with diabetes has specific limitations in the extent of the neural and humoral regulation of the heart and blood vessels. Therefore, the cardiovascular adjustments to exercise will be limited and can be directly contrasted and compared with an individual without diabetes.
Heart rate. At the onset of exercise, there is a centrally generated signal that simultaneously activates the cardiovascular and motor centers. This concept is referred to as central command. Central command results in the withdrawal of cardiac parasympathetic (vagal) efferent activity. The vagus nerve acts as a brake on HR. Vagal withdrawal, or releasing the brake, increases HR to -loo-120 beats/min. Beyond a HR of 100 beats/min, sympathetic efferent activity is activated to further increase HR up to the age-related maximum (220 beats/min -age in years). Cardiac sympathetic efferent fibers release norepinephrine activating cardiac P,-adrenoreceptors on the sinoatrial node, which functions as an accelerator on HR. Activation of sympathetic efferent nerves innervating the adrenal gland induce the release of catecholamines (epinephrine and norepinephrine) stored within the adrenal medulla. Circulating catecholamines released from the adrenal medulla also activate cardiac 131-adrenoreceptors. Cardiac sympathetic efferent nerve activity and circulating catecholamines increase HR in a linear fashion, with oxygen consumption up to -75% Vozmax.
The activation of sympathetic efferent activity is mediated by the muscle metaboreflex and the arterial baroreflex. The muscle metaboreflex is activated when there is a mismatch between muscle oxygen supply and demand. An increase in demand that is not adequately met by an increase in supply activates receptors located within the muscle to reflexly activate the sympathetic nervous system. The unloading of the arterial baroreflex reflexly increases sympathetic nerve activity. Unloading of the arterial baroreflex occurs when vascular resistance decreases more than CO increases.
Diabetes is associated with autonomic neuropathies, which result in a decline of parasympathetic and sympathetic influences on the heart. A reduction in parasympathetic tone to the heart results in an increase in the resting HR due to the lack of the braking effect on cardiac acceleration. The tachycardic response (increase in HR) at the onset of exercise is attenuated due to the delay in parasympathetic withdrawal. A reduction in the sympathetic
drive to the heart attenuates the HR response during exercise. In addition, a decreased number of cardiac Pi-adrenoreceptors also contributes to the attenuated HR response to increasing workloads.
The intrinsic HR is the heart's inherent ability to beat independently of neural innervation. Individuals with diabetes are often associated with a decreased intrinsic HR due to a decrease in the compliance of the myocardial wall and impaired myocardial calcium metabolism (Fig. 1) . 
Stroke volume. SV is the volume of blood ejected into the aorta with each contraction of the heart. It is a function of venous return or preload, contractility, and resistance to ejection or afterload. SV increases as a result of an increase in venous return and/or contractility. The increase in venous return lengthens the ventricular myocardial fiber and, in accordance with the Frank-Starling mechanism or lengthtension relationship, the force of contraction increases, which results in an increase in SV. Increases in HR, cardiac sympathetic efferent activity, and catecholamines increase the influx of calcium into the myocardial cell. The increase of calcium influx contributes to an increase in contractility and thus SV. Catecholamines, in particular epinephrine released by the adrenal medulla, are of particular importance in maintaining SV during severe exercise.
An increase in afterload or aortic pressure decreases SV. Afterload is the pressure that the left ventricle must pump against during the rapid ejection phase of the cardiac cycle. In order for rapid ejection of blood to occur, the aortic semilunar valves open as a result of the pressure difference between the left ventricle and the aorta, that is, the generated pressure in the left ventricle must be greater than the pressure in the aorta. If the afterload is increased, then the generated pressure in the left ventricle must be greater to eject a given blood volume. In this situation, SV decreases.
During exercise, venous return is increased by means of the muscle pump compressing and expanding peripheral veins. Consequently, left ventricular EDV increases, the length of the cardiac muscle fiber is increased, and, in accordance with the FrankStarling law of the heart, contractility increases. The increase in contractility ejects a greater quantity of blood out of the heart, and thus SV increases. In addition, the sudden and rapid increase in HR mediated by vagal withdrawal allows for more calcium to enter the myocardial cell, which in turn also increases contractility and consequently SV. The greatest increase in SV occurs up to 35-40% +ozmax.
Beyond 35-40% ?oZmax, SV changes very little. A small increase in afterload as a result of an increase in MAP may oppose the rise in SV.
With increasing workloads, ventricular filling times are significantly shortened (from a resting HR of -80 beats/min to a maximal HR of 190 beats/min).
Despite the reductions in ventricular filling time, SV is maintained as long as adjustments in cardiac performance are made (2) . These adjustments include increases in cardiac sympathetic efferent activity and circulating epinephrine and decreases in resistance.
In individuals with diabetes, the attenuated HR response allows for a greater ventricular filling time, which increases left ventricular EDV. The increase in left ventricular EDV increases the length of the muscle fiber, and contractility is increased by the Frank-Starling mechanism. Despite the FrankStarling mechanism, several factors in the individual with diabetes oppose the rise in SV. These factors include an increase in afterload due to a stiffening in the arterial vasculature, a diminution in cardiac sympathetic efferent outflow and sympathetic efferent outflow to the adrenal medulla, a decrease in the number of cardiac pi-adrenoreceptors, and a decrease in myocardial compliance (Fig. 2 10. Determine CO at rest in the two individuals (Fig. 4) . Subsequently, determine the components of CO at rest (Figs. 1 and 2 ). What accounts for this difference in resting CO between the two individuals?
11. Determine CO at an oxygen consumption of SBP is the pressure exerted by the blood against the walls of the arteries when the heart is contracting (systole). SBP is a function of the volume of blood ejected into the aorta during ventricular systole or SV and compliance of the aorta. A greater SV increases the volume of blood within the arteries and thus increases SBP. When blood is ejected into the aorta, the vessel expands and absorbs the energy. If the aorta fails to adequately expand during systole (decreased compliance), the energy is not absorbed, and SBP increases.
At the onset of exercise, the initial increase in SBP is the result of an increase in SV (Fig. 2) up to 3540% ir0 2max. SV increases due to an increase in venous return and myocardial contractility. At workloads > 35-40% \j02max, SV levels off, yet SBP continues to increase gradually. Despite a leveling off of SV, the volume of blood ejected into the aorta per minute (i.e., CO) continues to rise due to an increase in HR.
In addition, as CO increases, aortic compliance decreases. A decrease in aortic compliance will contibute to the elevation of SBP. The decrease in aortic compliance increases SBP because the energy generated during ventricular systole is not absorbed by the aorta.
In the individual with diabetes, there is a decrease in vascular compliance due to the proliferation of connective tissue into the vessel wall. Thus the vascular system fails to expand adequately during ventricular ejection, the energy of the ejected blood is not absorbed, and SBP increases. However, the increase in SBP is attenuated in the individual with diabetes due to the inability to substantially elevate SV. With increasing workloads, several factors oppose the rise in SBP. The levelling off of SV and the attenuated HR response are not sufficient to maintain CO. Even though individuals with diabetes are associated with a decrease in aortic compliance, SBP does not continue to rise because CO is not maintained (Fig. 5) .
Complete Table 5 (as in Table 1 ) by considering the factors that influence SBP, how they change with diabetes, and how they affect SBP in the individual with diabetes (i.e., does this variable increase, decrease, or remain unchanged). Diastolic blood pressure. DBP is the pressure exerted by the volume of blood remaining in the arteries when the heart is at rest (diastole). It is a function of the length of time the heart is at rest or HR, compliance of the vasculature, and the outflow of blood into the periphery (resistance). An increase in HR reduces the length of time spent between each cardiac contraction. Consequently, the inflow of blood into the vasculature is increased. Thus blood volume in the vasculature increases during diastole, and DBP increases. Compliance also has an effect on DBP. A vessel with a high compliance expands during systole and rebounds during diastole. In turn, the rebound effect delivers energy into the vascular system. Consequently, DBP increases. If the vessel has a decreased compliance, the rebound effect is reduced, and DBP is lower. Peripheral resistance is regulated by sympathetic nerves (activating a,-adrenoreceptors), hormones (arginine vasopressin and the renin-angiotensin system), and local metabolites (adenosine and nitric oxide) acting on the vasculature. Increases in peripheral resistance increase DBP by impeding the outflow of blood. Likewise, decreases in peripheral resistance decrease DBP by permitting the outflow of blood. Figure 6 demonstrates that, during exercise, DBP decreases slightly in an individual without diabetes. Although HR increases in this individual (Fig. l) , vasodilator mechanisms, such as locally produced metabolites, autoregulation, and flow-mediated release of nitric oxide, decrease peripheral resistance.
The balance between the increase in HR (increase DBP) and decrease in peripheral resistance (decrease DBP) results in a reduction in DBP. During exercise, arterial pressure is monitored by the arterial baroreflex and the muscle metaboreflex. If cardiac performance of the heart is not adequate to elevate CO and maintain arterial pressure, the arterial baroreflex and muscle metaboreflex are activated to reflexly increase sympathetic outflow. As previously discussed, the individual with diabetes demonstrates a compromised CO response to exercise. Thus, to maintain MAP, the arterial baroreflex and muscle metaboreflex increase peripheral resistance. The increase in peripheral resistance is necessary to compensate for the attenuated CO response.
Complete pulse pressure = systolic pressure -diastolic pressure MAP, determined by SBP and DBP, is the product of CO and total peripheral resistance. Factors influencing CO and total peripheral resistance will alter SBP and DBP. Ultimately, MAP will change. In the individual without diabetes, CO sharply increases (due to increases in SV and HR) at the onset of exercise. The rise in CO increases SBP and, therefore, MAP. At higher workloads when SV levels off, MAP is increased due to an increase in CO mediated by an elevated HR and contractility. Simultaneously, DBP decreases due to a reduction in total peripheral resistance. However, the increase in CO usually
exceeds the decrease in peripheral resistance, and thus MAP increases.
During exercise, arterial pressure is maintained and modulated by the arterial baroreflex and muscle metaboreflex. If CO is not adequate to maintain arterial pressure, the arterial baroreflex and muscle metaboreflex reflexly increase sympathetic efferent nerve activity. Recall Fig. 4 , which demonstrates that, in an individual with diabetes, the CO response to exercise is attenuated. The attenuated CO unloads the arterial baroreceptors and activates the muscle metaboreflex. These reflexes activate the sympathetic nervous system, which constricts arterioles and attenuates the reduction in peripheral resistance to compensate for the reduction in cardiac performance (Figs. 7 and 8; 26. In the individual with diabetes, CO begins to level off at 50% Go 2 max (Fig. 4 ). Yet, MAP continues to increase. What mechanisms mediate the increase in MAP?
27. In the individual with diabetes, an oxygen consumption of 2 1lmi.n ( Total peripheral resistance. Peripheral resistance reflects the state of vasoconstriction and/or vasodila tation and measures the resistance to blood flow. Resistance is directly related to blood viscosity and vessel length and is inversely related to (vessel radius)*. Accordingly, the radius of the vessel is the single most important factor regulating total peripheral resistance since resistance varies inversely to the fourth power of the radius. Thus very small changes in arteriole radius have a significant effect on resistance. There are several factors that contribute to the radius of the arteriole. Recall from the discussion on DBP that the arteriole radius is regulated by both vasoconstrictor and vasodilatory influences. Vasoconstrictor influences are mediated by sympathetic efferent nerves activating q-adrenoreceptors and hormones such as arginine vasopressin and the renin-angiotensin system. Vasodilatory influences are mediated by locally produced metabolites such as adenosine, flow-dependent endothelialderived relaxing factors such as nitric oxide, and autoregulation. Autoregulation refers to the tissue's ability to control its own blood flow. Figure 9 illustrates that peripheral resistance decreases sharply at the onset of exercise, continues to decline with increasing workloads, and levels off at -75%Vozmax. At the onset of exercise, the accumulation of local metabolites released by the exercising muscle elicits vasodilatation, which decreases perfusion pressure. In turn, autoregulatory mechanisms cause the upstream vessel to dilate. Blood flow to this bed is now significantly increased. The sheer stress acting on the vascular endothelium stimulates the release of flow-dependent endothelial-derived relaxing factor nitric oxide, which also contributes to vasodilatation. It appears that the intense vasodilatory stimulus should decrease MAP. However, the increase in CO usually exceeds the decrease in peripheral resistance, and thus blood pressure increases. If CO does not exceed the decrease in peripheral resistance, MAP will begin to decline. In response to the fall in blood pressure, arterial baroreceptors located in the carotid sinus and aortic arch are unloaded, which reflexly increases sympathetic efferent outflow. Sympathetic outflow to the vasculature functions to attenuate the fall in periph- The decrease in peripheral resistance compensates well for the increase in CO. That is, the higher the maximal CO in an individual (as in the individual without diabetes), the greater the decrease in peripheral resistance. There are two points to be made at this time. First, it is important that resistance decreases. If resistance increased or stayed the same in the presence of an increase in CO, MAP would increase to a phenomenally high value. For example, at rest in the individual without diabetes, MAP is 90 mmHg (5.6 l/min x 16 mmHgl-l=min-l decreased the SAME percentage (26%) as in the individual without diabetes. Therefore, in the individual with diabetes who has a limited CO, resistance cannot decrease to the same extent or MAP would decrease to a dangerously low value. Individuals with diabetes also have impaired local vascular regulatory mechanisms (decreased response to metabolites and nitric oxide). The impaired local vascular regulatory mechanisms also contribute to the elevated peripheral resistance.
Complete Table 9 (as in Table 1 ) by considering the factors that influence total peripheral resistance, 31. Determine the resistance unit at a HR of 100420 beats/min for both individuals.
Muscle bloodflow.
Blood flow to any tissue bed is directly proportional to pressure and is inversely proportional to the resistance (flow = pressure/ resistance). Muscle blood flow is regulated by local, humoral, and neural mechanisms. At rest, the nervous system and local metabolites are the primary regulators of muscle blood flow. During exercise, the nervous system, hormones, local metabolites, and flow-dependent endothelial-derived factors interact to regulate muscle blood flow.
At the onset of exercise, locally produced metabolites serve to increase muscle blood flow by decreasing resistance in the muscle vasculature. Autoregulation and the release of nitric oxide also contribute to the increase in muscle blood flow. Once HR reaches loo-120 beats/min, the activity of the sympathetic nervous system is increased. Sympathetic activation does several things. First, postganglionic sympathetic nerves release norepinephrine, which activates al-adrenoreceptors located on the vascular smooth muscle. a,-Adrenoreceptor activation elicits constriction of the vessel. Second, sympathetic activation on the adrenal medulla causes the release of epinephrine and norepinephrine. Circulating epinephrine binds to P,-adrenoreceptors located on the arteriole to elicit dilation and, with lesser affinity, cx,-adrenoreceptors to elicit vasoconstriction. Circulating norepinephrine binds to cxl-adrenoreceptors and elicits vasoconstriction. Because there are a greater number of cx,-adrenoreceptors compared with P,-adrenoreceptors, the vasoconstrictor effect dominates. Additionally, circulating epinephrine binds to P,-adrenoreceptors on the myocardium to increase HR. Third, sympathetic activation to the kidney stimulates the release of renin, which is then quickly converted to the potent vasoconstrictor angiotensin II. Together, vasoconstrictor responses maintain MAP by matching CO with peripheral resistance. As the vasodilator stimulus becomes greater with increasing workloads, the vasoconstrictor response becomes enhanced such that the muscle bed becomes a major site of vasoconstriction to maintain blood pressure.
In an individual with diabetes, the chronic elevations of glucose induce endothelial cell dysfunction, which results in abnormal vasodilatation. In addition, CO fails to increase to a level adequate to meet the metabolic demands with increasing workloads. Despite endothelial cell dysfunction, vasodilatation in the muscle bed occurs at a faster rate than the increase in CO. Therefore, in the individual with diabetes who has a limited CO, resistance cannot decrease to the same extent or MAP would decrease. To oppose a decrease in MAP, aortic and carotid sinus baroreceptors reflexly increase sympathetic efferent activity. In addition, muscle metaborecep- tors are activated, which also reflexly increase sympathetic efferent activity (Fig. 10 ).
Complete Splanchnic and renal blood flow. As previously discussed, blood flow to any tissue bed is directly proportional to pressure and is inversely proportional to the resistance (flow = pressure/resistance). Splanchnic and renal blood flow is regulated by local, humoral, autoregulation, and neural mechanisms. At the onset of exercise, blood flow to the exercising muscle increases. Furthermore, muscle blood flow increases in proportion to the level of exercise intensity.
Reductions in blood flow to the splanchnic and renal vasculature result in redistribution of CO to the active skeletal muscle.
When HR reaches loo-120 beats/min, sympathetic efferent nerves release norepinephrine onto the sinoatrial node to further increase HR and contractility, as previously discussed. Additionally, norepinephrine activates cxl-adrenoreceptors located on the splanchnic and renal vasculature eliciting vasoconstriction.
Splanchnic and renal vasoconstriction serves two functions.
First, it facilitates an increase in muscle blood flow (Fig. 11) Complete Table 11 (as in Table 1 ) by considering the factors that affect splanchnic and renal blood flow, how they change with diabetes, and how they affect splanchnic and renal blood flow in the individual with diabetes (i.e., does this variable increase, decrease, or remain unchanged).
36. Calculate the percent decrease in splanchnic or renal blood flow from rest (0%) to 50% Go, max in the individual without diabetes. Why is this decrease necessary during exercise? a-v oxygen dijfierence. The a-v oxygen difference refers to the ability of a vascular bed to extract oxygen. It is the difference in the oxygen content between the arterial and venous end of the capillary. The oxygen saturation of arterial blood is -98% (arterial partial pressure of oxygen is 100 mmHg), whereas the oxygen saturation of venous blood is 75% (venous partial pressure of oxygen is 40 mmHg).
Arterial oxygen content is the product of hemoglobin concentration (15 g Hg/ 100 ml blood) and oxygen-carrying capacity of hemoglobin (1.34 ml
OJlOO ml blood). Thus the arterial oxygen content is -20 ml OJlOO ml blood, and venous oxygen content is -15 ml OJlOO ml blood. The a-v oxygen difference (20 ml OJlOO ml blood; 15 ml OJlOO ml blood) is the result of metabolizing tissues extracting -5 ml OJlOO ml blood. This means, for every 100 ml blood that pass through the capillary bed, 5 ml oxygen diffuses into the tissue bed. During maximal exercise when the metabolism of the muscle substantially increases, the a-v oxygen difference can increase up to 15 ml OJlOO ml blood.
During exercise, the active muscle has a built-in mechanism for releasing more oxygen from the hemoglobin molecule. This mechanism is referred to as the Bohr effect. The Bohr effect is a principle that describes a rightward shift of the hemoglobinoxygen dissociation curve in response to a decrease in pH. In addition, an increase in carbon dioxide or temperature induces a rightward shift. A rightward shift of the hemoglobin-oxygen dissociation curve results in a situation in which oxygen is released from the hemoglobin more readily and at a higher partial pressure. Thus the oxygen is available to diffuse into the muscle cell. As a result of the Bohr effect, the oxygen content of venous blood during exercise is -2 ml OJlOO ml blood compared with 15 ml OJlOO ml blood at rest.
In the individual with diabetes, there is a reduction in CO (Fig. 4) and muscle blood flow (Fig. 10 ) during exercise. These limitations could potentially result in reduced transport of oxygen to the muscle. Despite these limitations, the a-v oxygen difference in this individual widens in a manner similar to that observed in the individual without diabetes. Furthermore, the a-v oxygen differences between the two individuals when expressed in relative units are virtually identical. Thus, when CO is limited and fails to meet the metabolic demands during exercise, the a-v oxygen difference increases even further to satisfy the oxygen demands of the exercising muscle.
To calculate the a-v oxygen difference, principle is used. Fick equation
where Voz minute. Accordingly, the a-v oxygen difference can be calculated by knowing the volume of oxygen consumed per minute and the CO (Figs. 12 and 13 ).
38. Using the Fick principle and Fig. 3 , calculate the a-v oxygen difference at rest and during exercise in the individuals with and without diabetes. Plot the results in Fig. 12 .
Complete Table 12 (as in Table 1 ) by considering the factors that affect a-v oxygen difference, how they change with diabetes, and how they affect a-v 1. In the individual without diabetes, HR increased to -45 beats/min from rest to 0.75 l/min oxygen consumption. In the individual with diabetes, HR increased to -24 beats/min from rest to 1.0 l/min oxygen consumption. The initial rapid increase in HR, up to -loo-120 beats/min, is due to vagal withdrawal. Vagal efferent activity acts as a brake on cardioacceleration. Releasing the brake (vagal withdrawal) increases HR. In the individual without diabetes, the increase in HR to 120 beats/min occurs at -25% of the *02,, (0.75 Urnin). HOWever, the individual with diabetes must work at 50% +0 2max to achieve the identical HR response. 2. Resting HR is 20% higher in the individual with diabetes. The autonomic nervous system functions to modulate HR. Parasympathetic activity functions to decrease HR, whereas sympathetic activity increases HR. At rest, parasympathetic activity dominates. Therefore, an elevated resting HR may indicate a reduced parasympathetic activity or an enhanced sympathetic activity to the heart. HOWever, because individuals with diabetes have autonomic neuropathies and a reduced number of p l-adrenoreceptors, the likely explanation for the elevated resting HR is an attenuated parasympathetic inhibitory influence.
3. Once again, the individual with diabetes demonstrates a depressed HR response at a given workload (Fig. 1B) . This individual must work at a greater percent of the Voz,, to achieve the same increase in HR, that is, the increase in HR is less than that achieved in the individual without diabetes at any given percent of the Vozmax. Thus the slope of the line is decreased from workloads of 1.3 to 1.7 l/min in the individual with diabetes. However, this is a result of structural, biochemical, and functional impairment of cardiac sympathetic efferent nerves (autonomic neuropathies) and a reduction in the number of cardiac p,-adrenoreceptors.
4. Maximal HR is -27% lower in the individual with diabetes. Maximum HR is achieved by cardiac sympathetic efferent nerves activating cardiac pl-adrenoreceptors on the sinoatrial node and to a lesser extent by circulating epinephrine and norepinephrine released from the adrenal medulla. Because the individual with diabetes has an impairment of the autonomic nervous system and a decrease in pladrenoreceptor numbers as previously described, this individual does not have the mechanisms required to reach an age-related maximum HR. In addition, changes in the peripheral circulation (blood flow to the working muscles is reduced, which is mediated in part by an increased peripheral resistance) result in local muscle fatigue, which significantly limits exercise tolerance.
5. The resting SV is -2 1% lower in the individual with diabetes. SV is a function of preload, afterload, and contractility. In individuals with diabetes, afterload (MAR, see Fig. 8 ) is the same at rest. However, contractility is reduced due to diabetic myopathies and a decrease in the number of cardiac piadrenoreceptors. Additionally, preload is reduced due to a decrease in myocardial compliance. Thus a reduced preload and contractility account for the lower resting SV in the individual with diabetes. In addition, the slightly higher HR at rest in the individual with diabetes slightly reduces ventricular filling time, which may also contribute to the reduction in SV.
6. From rest to 50% Vozmax, SV increased 70 ml in the individual without diabetes and 59 ml in the individual with diabetes. In both individuals, the initial increase in SV ( Fig. 2A) is due to an increase in venous return mediated by the action of the muscle pump. However, the individual with diabetes has a reduced myocardial compliance, and thus the heart does not expand to sufficiently increase EDV. Therefore, at the same percentage of Vo2,, (Fig. 2B ), the individual with diabetes has a significantly reduced SV response. Interestingly, the reduced HR allows for an increased ventricular filling time. However, because the myocardium is less compliant, the individual with diabetes cannot take full advantage of the reduced HR (increase ventricular filling time). This concept may best be explained by relating what happens to SV when an individual is taking a &adrenoreceptor blocker. The P1-adrenoreceptor blocker reduces HR at rest and during exercise. The reduced HR increases ventricular filling time so that these individuals have an increased SV.
7. The plateau in SV occured at -40-50% Vozmax in both individuals. At 50% Vozmax, SV in the individual without diabetes is 140 ml. At 50% Vozmax, SV in the individual without diabetes is 114 ml. Thus, at 50% vo 2ms7 SV does not rise to the same level as in the individual without diabetes. Furthermore, Fig. 2 demonstrates that the rise in SV is attenuated at all workloads in the individual with diabetes. SV is a function of preload, afterload, and contractility. A
decrease in contractility accounts for the decreased SV response during exercise. This is due to cardiac myopathy caused by an alteration in autonomic function, decreased myocardial compliance, decreased myocardial P,-adrenoreceptor number, and changes in subcellular organelles that control the movement of intracellular calcium. The decrease in myocardial compliance limits the distensibility of the heart during diastole. Thus preload is also decreased. Taken together, these factors attenuate pressure developed by the left ventricule and decreases the SV response during exercise in the individual with diabetes.
8. During ejection, the aortic semilunar valve opens, and blood is rapidly ejected into the aorta. For this to occur, the pressure in the left ventricle must be greater than the pressure in the aorta. Therefore, afterload is the aortic pressure that the heart must pump against during ejection. However, if the aortic pressure is increased, the heart must generate a greater pressure to eject a given blood volume.
9. Complete the CO graph.
10. CO is the product of HR and SV. In the individual without diabetes, resting CO is 5.6 l/m [ SV (70 ml)
x HR (80 beats/min)]. Although an individual with diabetes has a similar CO at rest (4.93 l/min), the diabetic myopathies and neuropathies elevate resting HR (90 beats/min) and reduce resting SV (55 ml). Thus the reduced CO is due to a reduced SV.
11. CO at an oxygen consumption of 1.5 l/min is 23 l/min for the individual without diabetes and 16 l/min for the individual with diabetes. At a CO of 23 l/min, the individual without diabetes is working at 50%V0zmax. At a CO of 16 l/min, the individual with diabetes is working at 64% VOW,,. These data demonstrate that, at a given oxygen consumption (i.e., 1.5 l/min), CO in the individual with diabetes does not rise to the same level as in the individual without diabetes. An increase in CO is due to an increase in SV and HR. However, the individual with diabetes is not able to increase CO to the same level for a given workload as the individual without diabetes due to the depressed HR ( Fig. 1) and SV (Fig. 2) responses to exercise.
12. The individual with diabetes has a 30% lower CO than the individual without diabetes at 100% tozmax.
This indicates, in part, that the individual with diabetes has a limited left ventricular function. CO is the volume of blood that the heart pumps per minute. In situations that demand an increased blood flow for the delivery of oxygen and rapid removal of metabolites, such as exercise, CO is increased. Because individuals with diabetes have a limited CO, oxygen delivery and metabolite removal do not occur at levels required to meet the demands of higher workloads. Thus individuals with diabetes experience muscle fatigue easily and have a reduced exercise tolerance. These data illustrate that CO is the limiting factor for exercise tolerance.
13. Resting SBP is 120 mmHg in the individual without diabetes and 110 mmHg in the individual with diabetes. Resting SBP is 10 mmHg lower in the individual with diabetes because resting SV (Fig. 2) is lower. The reasons for the lower SV are due to cardiac myopathies, which reduce left ventricular function, and a decreased myocardial compliance, which limits the increase in left ventricular EDV. The reduced aortic compliance associated with diabetes tends to increase SBP. It is important to note that the reduction in SV is greater than the decreased compliance at rest.
14. Both individuals demonstrate a rapid increase in SBP of 40 mmHg (nondiabetics: 120-160 mmHg; diabetics: 1 lo-150 mmHg). 16. In the individual without diabetes, SBP plateaus at 75% +ozmax. The plateau in CO (Fig. 4) is responsible for the plateau in SBP.
17. At workloads between 25 and 75% Vozmax, SBP continues to increase although not as rapidly as the increase that occurs at the onset of exercise. SBP gradually increases as a result of increases in contractility and HR (Fig. l) , increasing CO. The gradual increase in SBP is mediated by cardiac sympathetic efferent nerves activating cardiac P1-adrenoreceptors and, to a lesser degree, circulating catecholamines released by the adrenal medulla.
18. In the individual with diabetes, SBP plateaus at 50% VOzmax. The plateau occurs for several reasons. The plateau in SV and CO prevents a further increase in SBP beyond 50% i/bz,,.
In addition, cardiac myopathies, decreased myocardial compliance, and reduced number of cardiac P1-adrenoreceptors prevent further increases in SBP in the individual with diabetes.
19. Resting DBP is 80 mmHg in the individual without diabetes and 83 mmHg in the individual with diabetes. DBP is the pressure exerted by the volume of blood remaining in the arteries when the heart is at rest. DBP is dependent on HR and the outflow of blood into the periphery (resistance). The elevated resting HR (Fig. 1) decreases the time when the heart is at rest, and thus more blood remains in the arteries during diastole. The increased blood volume contributes to the elevated DBP. Total peripheral resistance is slightly higher (see Fig. 9 ) and also contributes to the elevated DBP. However, the decrease in aortic compliance lowers DBP. Taken together, the individual with diabetes has an elevated DBP at rest and during exercise.
20. From rest to the first workload, HR and SV increase. From the equation CO = HR X SV, it is clear that CO substantially increases. The increase in CO is sufficient to raise MAP without an increase in peripheral resistance (MAP = CO X total peripheral resistance). Therefore, DBP is unaltered. 2 1. From rest to the cessation of exercise, DBP decreased 3 mmHg. DBP decreases in the individual without diabetes because peripheral resistance decreases. During exercise, local metabolites released by the exercising muscle, autoregulation, and endothelial-released nitric oxide provide a strong vasodilator stimulus. The lower resistance facilitates the runoff of blood into the periphery during diastole. The elevated CO is opposed by an adequate reduction in peripheral resistance. Thus DBP decreases.
22. From rest to the cessation of exercise, DBP increased 7 mmHg. DBP increases in the individual with diabetes because of an inability of CO to maintain adequate tissue blood flow. The plateau in CO and tissue blood flow unloads the arterial baroreflex and activates the muscle metaboreflex. These reflexes activate the sympathetic nervous system, which constricts arterioles and attenuates the reduction in peripheral resistance. The elevated HR is not opposed by an adequate reduction in peripheral resistance, and thus DBP increases. At this point, it may be important to state that elevations in DBP are reasons to terminate exercise. Elevations in DBP indicate reductions in cardiac performance. To compensate for reductions in cardiac performance, the sympathetic nervous system is activated.
Complete the MAP graph.
24. In the individual without diabetes, resting MAP is 92 mmHg. At 25% VOW,,, MAP increased to 104 mmHg for an increase of 12 mmHg. In the individual with diabetes, resting MAP is 91 mmHg. At 25% i/bzmax, MAP increased to 97 mmHg for an increase of 6 mmHg. The initial increase in MAP in both individuals is due to a sharp increase in CO mediated by an increase in HR and SV. diabetes, MAP sharply increases at the onset of exercise due to an abrupt rise in CO and decrease in total peripheral resistance. With increasing workloads, CO gradually increases due to sympathetically mediated increases in contractility and HR. Thus MAP is maintained by an increase in CO. In the individual with diabetes, MAP also increases due to an abrupt rise in CO (although smaller than in the individual without diabetes) and decrease in total peripheral resistance. However, total peripheral resistance does not decrease to the same degree. In this individual, the CO response is attenuated due to the reduced SV. With increasing workloads the reduced CO reduces blood pressure and tissue blood flow. Consequently, the reduced blood pressure and blood flow unloads the arterial baroreflex and activates the muscle metaboreflex, which function to activate the sympathetic nervous system. Sympathetic efferent nerves constrict arterioles and attenuate the reduction in peripheral resistance.
With increasing workloads, a decrease in vascular compliance and augmented vasoconstrictor response, mediated by the arterial baroreflex and muscle metaboreflex, maintain MAP. Thus MAP is maintained by an increase in peripheral resistance. Taken together, it is clear that, in the individual without diabetes, MAP is elevated due to an increase in CO, whereas, in the individual with diabetes, MAP is elevated due to an attenuation in the decrease in peripheral resistance.
26. At higher workloads, MAP continues to increase in spite of a reduced cardiac pump function (CO). The reduced CO unloads the arterial baroreceptors and activates muscle metaboreceptors, which reflexly activate sympathetic efferent nerve activity. Thus DBP increases. As demonstrated previously, MAP= DBP + l/3 pulse pressure. An increase in DBP can increase MAP. The increase in DBP is a compensatory mechanism to increase MAP during exercise when CO is limited and is indicative of impaired cardiac pump function.
27. In the individual with diabetes, an oxygen consumption of 2 l/min corresponds to 63% \joamax.
28. At the onset of exercise, peripheral resistance dramatically decreases in both individuals although the response is attenuated in the individual with diabetes. At the onset of exercise, local metabolites released by the exercising muscle, autoregulation, and endothelial-released nitric oxide provide a stimulus for vasodilatation, and peripheral resistance decreases. The individual with diabetes has impaired local vascular regulatory mechanisms. Therefore, the vascular response to metabolites and nitric oxide are attenuated.
29. In the individual without diabetes, resting peripheral resistance is 16 mmHg l 1-l . min-l. At 50% i702max, peripheral resistance decreased to 4.8 mmHg l 1-l. min l for a decrease of 11.2 mmHg -1-l. min-l. In the individual with diabetes, resting peripheral resistance is 18 mmHg . I-la min-4
At 50% ire 2 max, peripheral resistance decreased to 7.5 mmHg -1-l l min-l for a decrease of 10.5 mmHg l I-l. min-4 Thus, in the individual with diabetes, peripheral resistance does not decrease to the same level as in the individual without diabetes. The peripheral resistance response is attenuated in the individual with diabetes because of an inability of CO to further elevate SBP and maintain adequate tissue blood flow. The plateau in CO and tissue blood flow unloads the arterial baroreflex and activates the muscle metaboreflex. These reflexes activate the sympathetic nervous system, which constricts arterioles and attenuates the reduction in peripheral resistance. In addition, the individual with diabetes has impaired local vascular regulatory mechanisms. Therefore, the vascular response to metabolites and nitric oxide is attenuated.
30. The peripheral resistance response to exercise levels off at 50% i/bzmax. This is observed in both individuals. As previously discussed, increases in HR beyond loo-120 beats/min are mediated by the sympathetic nervous system, which functions to further elevate HR and contractility. Simultaneously, sympathetic efferent nerves activate cx-adrenoreceptors located on the arterioles causing vasoconstriction. Arteriole vasoconstriction, mediated by the arterial baroreflex and muscle metaboreflex, attenuates the metabolite, autoregulatory, and nitric oxide vasodilatory stimulus, thus opposing further decreases in peripheral resistance at the higher workloads. The individual with diabetes takes advantage of the reflex-mediated vasoconstriction to compensate for the reduced CO in order to maintain blood In the individual with diabetes, resting muscle blood flow (Fig. 10) is 0.75 l/min. At 50% ir0 2 max7 muscle blood flow is 5.3 l/min (24% of CO).
At 100% V02mzy muscle blood flow is 10.7 l/min (56% of CO). Note that 56% of CO is shifted to the active muscle at iTg2ma. This is due, in part, to splanchnic and renal vascular vasoconstriction.
38. Complete the a-v oxygen difference graph.
39. The a-v oxygen difference is significantly enhanced in the individual with diabetes (Fig. 13A) .
However, at the same percent of oxygen consumption, the a-v oxygen difference is similar (Fig. 1W ) despite a reduced CO (Fig. 4) . This suggests that the ability of a vascular bed to extract oxygen compensates for the reduced CO. Furthermore, the Fick equation (Vo2 = CO x a-v 0,) demonstrates mathematically that the a-v oxygen difference must increase to compensate for a reduced CO to maintain oxygen consumption.
40. The increase in the a-v oxygen difference at absolute workloads (Fig. 13A) does not contribute significantly to exercise tolerance. This is demonstrated in Fig. 13B in which the a-v oxygen difference is similar at the same percentage of the Vo2ma for both individuals. Additionally, the a-v oxygen difference continues to increase with increasing workloads and does not level off as seen with SV, CO, and SBP. From the Fick equation, Vo, = CO X a-v 02, it is clear that CO is the limiting factor in oxygen consumption, not the a-v oxygen difference. 
